BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 20967796)

  • 1. Notch signalling in T-cell lymphoblastic leukaemia/lymphoma and other haematological malignancies.
    Aster JC; Blacklow SC; Pear WS
    J Pathol; 2011 Jan; 223(2):262-73. PubMed ID: 20967796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential regulation of Notch signal transduction in leukaemia and lymphoma cells in culture.
    Chiaramonte R; Calzavara E; Balordi F; Sabbadini M; Capello D; Gaidano G; Serra A; Comi P; Sherbet GV
    J Cell Biochem; 2003 Feb; 88(3):569-77. PubMed ID: 12532332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T cell acute lymphoblastic leukemia/lymphoma: a human cancer commonly associated with aberrant NOTCH1 signaling.
    Pear WS; Aster JC
    Curr Opin Hematol; 2004 Nov; 11(6):426-33. PubMed ID: 15548998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Notch signaling: switching an oncogene to a tumor suppressor.
    Lobry C; Oh P; Mansour MR; Look AT; Aifantis I
    Blood; 2014 Apr; 123(16):2451-9. PubMed ID: 24608975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Notch Receptors in Hematologic Malignancies.
    Gragnani L; Lorini S; Marri S; Zignego AL
    Cells; 2020 Dec; 10(1):. PubMed ID: 33374160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Notch signaling in T-cell acute lymphoblastic leukemia.
    Weng AP; Lau A
    Future Oncol; 2005 Aug; 1(4):511-9. PubMed ID: 16556027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Notch 1 activation in the molecular pathogenesis of T-cell acute lymphoblastic leukaemia.
    Grabher C; von Boehmer H; Look AT
    Nat Rev Cancer; 2006 May; 6(5):347-59. PubMed ID: 16612405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Notch pathway in cancer: differentiation gone awry.
    Sjölund J; Manetopoulos C; Stockhausen MT; Axelson H
    Eur J Cancer; 2005 Nov; 41(17):2620-9. PubMed ID: 16239105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Notch signaling: its roles and therapeutic potential in hematological malignancies.
    Gu Y; Masiero M; Banham AH
    Oncotarget; 2016 May; 7(20):29804-23. PubMed ID: 26934331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ligand-driven activation of the notch pathway in T-ALL and solid tumors: why Not(ch)?
    Indraccolo S; Minuzzo S; Masiero M; Amadori A
    Cell Cycle; 2010 Jan; 9(1):80-5. PubMed ID: 20016278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Notch signaling contributes to proliferation and tumor formation of human T-cell leukemia virus type 1-associated adult T-cell leukemia.
    Pancewicz J; Taylor JM; Datta A; Baydoun HH; Waldmann TA; Hermine O; Nicot C
    Proc Natl Acad Sci U S A; 2010 Sep; 107(38):16619-24. PubMed ID: 20823234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The tumor suppressor gene hCDC4 is frequently mutated in human T-cell acute lymphoblastic leukemia with functional consequences for Notch signaling.
    Malyukova A; Dohda T; von der Lehr N; Akhoondi S; Corcoran M; Heyman M; Spruck C; Grandér D; Lendahl U; Sangfelt O
    Cancer Res; 2007 Jun; 67(12):5611-6. PubMed ID: 17575125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. c-Myc is an important direct target of Notch1 in T-cell acute lymphoblastic leukemia/lymphoma.
    Weng AP; Millholland JM; Yashiro-Ohtani Y; Arcangeli ML; Lau A; Wai C; Del Bianco C; Rodriguez CG; Sai H; Tobias J; Li Y; Wolfe MS; Shachaf C; Felsher D; Blacklow SC; Pear WS; Aster JC
    Genes Dev; 2006 Aug; 20(15):2096-109. PubMed ID: 16847353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. It's T-ALL about Notch.
    Demarest RM; Ratti F; Capobianco AJ
    Oncogene; 2008 Sep; 27(38):5082-91. PubMed ID: 18758476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Notch signal transduction is not regulated by SEL1L in leukaemia and lymphoma cells in culture.
    Chiaramonte R; Calzavara E; Basile A; Comi P; Sherbet GV
    Anticancer Res; 2002; 22(6C):4211-4. PubMed ID: 12553058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulation of the Notch pathway mediated by a gamma-secretase inhibitor induces anti-tumour effects in mouse models of T-cell leukaemia.
    Tammam J; Ware C; Efferson C; O'Neil J; Rao S; Qu X; Gorenstein J; Angagaw M; Kim H; Kenific C; Kunii K; Leach KJ; Nikov G; Zhao J; Dai X; Hardwick J; Scott M; Winter C; Bristow L; Elbi C; Reilly JF; Look T; Draetta G; Van der Ploeg L; Kohl NE; Strack PR; Majumder PK
    Br J Pharmacol; 2009 Nov; 158(5):1183-95. PubMed ID: 19775282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High selective pressure for Notch1 mutations that induce Myc in T-cell acute lymphoblastic leukemia.
    Chiang MY; Wang Q; Gormley AC; Stein SJ; Xu L; Shestova O; Aster JC; Pear WS
    Blood; 2016 Nov; 128(18):2229-2240. PubMed ID: 27670423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Notch signalling in solid tumours: a little bit of everything but not all the time.
    Ranganathan P; Weaver KL; Capobianco AJ
    Nat Rev Cancer; 2011 May; 11(5):338-51. PubMed ID: 21508972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Notch signalling pathway and human diseases.
    Joutel A; Tournier-Lasserve E
    Semin Cell Dev Biol; 1998 Dec; 9(6):619-25. PubMed ID: 10075489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Notch Signaling: A Potential Therapeutic Target for Hematologic Malignancies.
    Gao L; Yuan K; Ding W; Lin M
    Crit Rev Eukaryot Gene Expr; 2016; 26(3):239-46. PubMed ID: 27650987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.